hMAO-B/MB-COMT-IN-1

• CAT Number: I042823
• CAS Number: 254974-70-4
• Molecular Formula: C16H19NO3
• Molecular Weight: 273.33
• Purity: ≥95%
• Synonyms: (2E,4E)-5-(3,4-dihydroxyphenyl)-1-piperidin-1-ylpenta-2,4-dien-1-one
• InChI: InChI=1S/C16H19NO3/c18-14-9-8-13(12-15(14)19)6-2-3-7-16(20)17-10-4-1-5-11-17/h2-3,6-9,12,18-19H,1,4-5,10-11H2/b6-2+,7-3+
• InChIKey: ZSGNXVFMAMFAQY-YPCIICBESA-N
• SMILES: C1CCN(CC1)C(=O)/C=C/C=C/C2=CC(=C(C=C2)O)O

hMAO-B/MB-COMT-IN-1（Cat No.:I042823）is a dual-target inhibitor designed to simultaneously block both human monoamine oxidase B (hMAO-B) and catechol-O-methyltransferase (MB-COMT). hMAO-B is an enzyme involved in the metabolism of neurotransmitters such as dopamine, and its inhibition is of interest in treating neurodegenerative diseases like Parkinson’s disease. MB-COMT is involved in the breakdown of catecholamines, and its inhibition may improve the efficacy of certain medications. This dual inhibition approach may enhance therapeutic outcomes in neurological disorders by increasing dopamine levels and optimizing neurotransmitter regulation. Research is ongoing to assess its clinical potential.